SULT1A2
Basic information
Region (hg38): 16:28591943-28597050
Previous symbols: [ "STP2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (57 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SULT1A2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001054.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 53 | 57 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 53 | 4 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SULT1A2 | protein_coding | protein_coding | ENST00000395630 | 7 | 5167 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.68e-12 | 0.0248 | 125005 | 9 | 734 | 125748 | 0.00296 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.846 | 211 | 179 | 1.18 | 0.0000108 | 1932 |
| Missense in Polyphen | 71 | 57.033 | 1.2449 | 720 | ||
| Synonymous | -0.389 | 74 | 69.9 | 1.06 | 0.00000430 | 551 |
| Loss of Function | -0.231 | 17 | 16.0 | 1.06 | 8.71e-7 | 165 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0239 | 0.0238 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0149 | 0.0148 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000325 | 0.000325 |
| Middle Eastern | 0.0149 | 0.0148 |
| South Asian | 0.00102 | 0.00101 |
| Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Is also responsible for the sulfonation and activation of minoxidil. Mediates the metabolic activation of carcinogenic N-hydroxyarylamines to DNA binding products and could so participate as modulating factor of cancer risk.;
- Pathway
- Chemical carcinogenesis - Homo sapiens (human);Sulfation Biotransformation Reaction;Arylamine metabolism;Metapathway biotransformation Phase I and II;Phase II - Conjugation of compounds;Biological oxidations;Metabolism;Cytosolic sulfonation of small molecules;thyroid hormone metabolism II (via conjugation and/or degradation);serotonin degradation;superpathway of tryptophan utilization;melatonin degradation I;superpathway of melatonin degradation
(Consensus)
Recessive Scores
- pRec
- 0.262
Intolerance Scores
- loftool
- 0.248
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 87.99
Haploinsufficiency Scores
- pHI
- 0.117
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.954
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- ethanol catabolic process;catecholamine metabolic process;xenobiotic metabolic process;steroid metabolic process;amine biosynthetic process;phenol-containing compound metabolic process;3'-phosphoadenosine 5'-phosphosulfate metabolic process;sulfation
- Cellular component
- cytosol
- Molecular function
- aryl sulfotransferase activity;protein binding;sulfotransferase activity;flavonol 3-sulfotransferase activity